Did not become law. It stopped in the Senate's Appropriations Committee on May 23, 2018. The 2017–2018 session has ended.
2017–2018 Regular Session
Senate Bill 1054
An Act providing for certification of buprenorphine office-based prescribers; limiting the use of buprenorphine; and imposing powers and duties on the Department of Drug and Alcohol Programs.
Sponsors
Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.
In the Senate
Sponsor
Its course
February 16 to May 23, 2018, on one scale. In the top row each mark is a day something happened; taller marks are busier days.
Each committee stop sits inside its chamber.
Every action5 actions on 3 days
In the SenateFeb 16 to May 23 · stopped96 days
Health & Human ServicesFeb 16 to May 2295 days
AppropriationsMay 23 to May 23 · stopped0 days
Amendments
Each amendment offered, and what became of it.
Senate committee amendmentAdopted
Adopted May 22
Text
Each version as the General Assembly printed it.
l9n doesn't hold this bill's text yet.
What happened
In l9n's words, one line for each step. Every action as the General Assembly published it is below.
In the Senate Feb 16 – May 23
- Feb 16Sent to HEALTH AND HUMAN SERVICES
- May 22HEALTH AND HUMAN SERVICES recommended it as amended
- May 23Read a second time
- Sent to APPROPRIATIONS
All 5 actions, as published
- Feb 16Referred to HEALTH AND HUMAN SERVICES, Feb. 16, 2018 [Senate]Senate
- May 22Reported as amended, May 22, 2018 [Senate]Senate
- May 22First consideration, May 22, 2018 [Senate]Senate
- May 23Second consideration, May 23, 2018 [Senate]Senate
- May 23Re-referred to APPROPRIATIONS, May 23, 2018 [Senate]Senate